|
VPS25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.81229508966885E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1197999999778E-07 |
| Normal-vs-Stage2 |
1.175950E-04 |
| Normal-vs-Stage3 |
1.48849821357544E-11 |
| Normal-vs-Stage4 |
1.60630000411999E-08 |
| Stage1-vs-Stage2 |
5.404000E-01 |
| Stage1-vs-Stage3 |
3.139100E-03 |
| Stage1-vs-Stage4 |
2.903800E-01 |
| Stage2-vs-Stage3 |
3.825800E-01 |
| Stage2-vs-Stage4 |
9.915200E-01 |
| Stage3-vs-Stage4 |
1.370180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.81150707954248E-12 |
| Normal-vs-AfricanAmerican |
1.68195999999954E-05 |
| Normal-vs-Asian |
7.553200E-01 |
| Caucasian-vs-AfricanAmerican |
4.525000E-01 |
| Caucasian-vs-Asian |
2.456200E-01 |
| AfricanAmerican-vs-Asian |
2.885200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48192569326966E-12 |
| Normal-vs-Female |
9.55610000019647E-07 |
| Male-vs-Female |
2.023000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.610430E-01 |
| Normal-vs-Age(41-60Yrs) |
1.07319997333377E-09 |
| Normal-vs-Age(61-80Yrs) |
1.65349955949523E-11 |
| Normal-vs-Age(81-100Yrs) |
1.020240E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.124400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.599800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.367200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.694800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.286400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.738600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.75680000000278E-05 |
| Normal-vs-Grade 2 |
5.91840000008226E-07 |
| Normal-vs-Grade 3 |
2.40569786313927E-11 |
| Normal-vs-Grade 4 |
8.53299997327639E-09 |
| Grade 1-vs-Grade 2 |
7.952600E-01 |
| Grade 1-vs-Grade 3 |
9.169600E-02 |
| Grade 1-vs-Grade 4 |
1.316390E-01 |
| Grade 2-vs-Grade 3 |
5.738100E-02 |
| Grade 2-vs-Grade 4 |
1.213570E-01 |
| Grade 3-vs-Grade 4 |
9.897200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.06810054929008E-10 |
| Normal-vs-ccB subtype |
1.00049999951501E-07 |
| ccA subtype-vs-ccB subtype |
8.750000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33940000038402E-07 |
| Normal-vs-N1 |
1.206200E-01 |
| N0-vs-N1 |
3.211600E-01 |
|
|
